Abstract
The effects of histamine and 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline(salsolinol) on debrisoquine 4-monooxygenation, which is catalyzed by cytochrome P-450db1(CYP2D1) in rat liver microsomes, were studied. Both histamine and salsolinol competitively inhibited the activity of debrisoquine 4-monooxygenase (Ki=0.31 and 0.43 mM, respectively). These data demonstrate that histamine and salsolinol bind to the active site of CYP2D1, i.e. histamine and salsolinol have structures (molecular shape) corresponding to the active site of CYP2D1.
This is a preview of subscription content, log in via an institution to check access.
References
Fonne-Pfister R, Meyer UA (1988) Xenobiotic and endobiotic inhibitors of cytochrome P-450 db1 function, the target of the debrisoguine/spartein type polymorphism. Biochem Pharmacol 37: 3829–3835
Fukui H, Wang NP, Watanabe T, Wada H (1988) Solubilization, characterization and partial purification of [3H] mepyramine-binding protein, a possible histamine H, receptor, from rat liver membrane. Jap J Pharmacol 46: 127–139
Kararia RN, Mitchell MJ, Harik SI (1987) Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood-brain barrier monoamine oxidase activity. Pro Natl Acad Sci USA 84: 3521–3525
Kronbach T, Mathys D, Gut J, Catin T, Meyer UA (1987) High-performance liquid Chromatographic assays for bufuralol 1′-hydroxylase, debrisoguine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver. Anal Biochem 162: 24–32
Lennard MS, Crewe HK, Tucker GT, Woods HF (1986) Histamine: an inhibitor of cytochrome P-450-catalysed drug metabolism. Biochem Pharmacol 35: 2459–2460
Matsuo Y, Iwahashi K, Ichikawa Y (1992) Debrisoguine 4-monooxygenase and bufuralol 1′-monooxygenase activities in bovine and rabbit tissues. Biochem Pharmacol 43: 1911–1919
Mitoma C, Posner HS, Reitz HC, Udenfriend S (1956) Enzymatic hydroxylation of aromatic compounds. Arch Biochem Biophys 61: 431–441
Morris CQ, Tucker GT, Crewe HK, Harlow JR, Woods HF, Lennard MS (1989) Histamine inhibition of mixed function oxidase activity in rat and human liver microsomes and in the isolated perfused rat liver. Biochem Pharmacol 38: 2639–2644
Nebert DW, Nelson DW, Coon NJ, Estabrook RW, Feyereisen R, Fujii-Kuriyama Y, Gonzalez FJ, Guengerich FP, Johnson EF, Loper JC, Sato R, Waterman MR, Waxman DJ (1991) The P-450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. DNA 10: 1–14
Ogawa N, Yamamoto M (1985) In: Kuroiwa Y, Toyokura Y (eds) Current problems in treatment of Parkinson's disease. DMW Japan Press, Tokyo, pp 23–32
Seeman P (1985) In: Kalant H, Roschlau WHE, Sellers EM (eds) Principles of Medical Pharmacology, University of Toronto Press, Toronto, pp 321–336
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Iwahashi, K., Matsuo, Y., Tsuneoka, Y. et al. Histamine and 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline are competitive inhibitors of debrisoquine 4-monooxygenase in rat liver. Arch Toxicol 67, 514–516 (1993). https://doi.org/10.1007/BF01969924
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01969924